Scott Brunner, CAE, CEO of the Alliance for Pharmacy Compounding (APC), joins co-hosts Mike De Lisio and Sebastian Denison, RPh, FAARM (candidate), to discuss the recent NASEM report on compounded hormone therapy and what it means to the pharmacy compounding industry. They also discuss regulatory issues that all compounding pharmacies should be aware of.
